IP Library Granted Patent US 11,406,107
Granted Patent B2
US 11,406,107 · App. 16/935,020 · Granted Aug 9, 2022

Compositions comprising recombinant bacillus cells and another biological control agent

Inventors: Damian Curtis (Davis, CA); Brian Thompson (Creve Coeur, MO)
Assignees: Bayer CropScience LP; Spogen Biotech Inc.
A01N63/50C07K14/325C12N15/63C12N15/82C12N15/866A01N25/00A61K38/00C12N15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,107
App. No.
16/935,020
Granted
Aug 9, 2022
Kind
B2
Abstract

The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one further biological control agent selected from particular microorganisms disclosed herein and/or a mutant of a specific strain of a microorganism disclosed herein having all identifying characteristics of the respective strain, and/or at least one metabolite produced by the respective strain, and/or at least one metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

Claims (32)

1. A composition comprising:

a) recombinant exosporium-producing Bacillus cells of a Bacillus cereus family member that express a fusion protein comprising:

(i) a cellulase; and

(ii) a targeting sequence, exosporium protein, or exosporium protein fragment, wherein the targeting sequence or exosporium protein comprises:

an amino acid sequence having at least about 43% identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at least about 54%;

a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 22-31 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 22-33 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 20-31 of SEQ ID NO: 1;

a targeting sequence comprising SEQ ID NO: 1; or

an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO: 2; and

b) at least one biological control agent selected from the group consisting of Bacillus thuringiensis, Bacillus megaterium, Bacillus mycoides isolate J, Bacillus methylotrophicus, Bacillus vallismortis, Chromobacterium subtsugae, Delftia acidovorans, Streptomyces lydicus, Streptomyces colombiensis, Streptomyces galbus K61, and Penicillium bilaii in a synergistically effective amount.

2. The composition according of claim 1 , wherein the Bacillus cereus family member is selected from the group consisting of Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, Bacillus mycoides, Bacillus pseudomycoides, Bacillus samanii, Bacillus gaemokensis, Bacillus weihenstephensis, Bacillus toyoiensis and combinations thereof.

3. The composition according to claim 1 , wherein the fusion protein is expressed under the control of a high-expression sporulation promoter.

4. The composition of claim 3 , wherein the high-expression sporulation promoter comprises a sigma-K sporulation-specific polymerase promoter sequence.

5. The composition according to claim 1 , wherein the at least one biological control agent is a Bacillus thuringiensis strain.

6. A seed coated with the composition according to claim 1 .

7. A method of treating a plant, a plant part, or the locus surrounding the plant to enhance plant growth and/or promote plant health comprising the step of simultaneously or sequentially applying:

a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising:

(i) a cellulase; and

(ii) a targeting sequence, exosporium protein, or exosporium protein fragment, wherein the targeting sequence or exosporium protein comprises:

an amino acid sequence having at least about 43% identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at least about 54%;

a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 22-31 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 22-33 of SEQ ID NO: 1;

a targeting sequence comprising amino acids 20-31 of SEQ ID NO: 1;

a targeting sequence comprising SEQ ID NO: 1; or

an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO: 2; and

b) at least one biological control agent selected from the group consisting of a Bacillus thuringiensis, Bacillus megaterium, Bacillus mycoides isolate J, Bacillus methylotrophicus, Bacillus vallismortis, Chromobacterium subtsugae, Delftia acidovorans, Streptomyces lydicus, Streptomyces colombiensis, Streptomyces galbus K61, and Penicillium bilaii;

in a synergistically effective amount.

Assignments (4)
CHANGE OF NAME Recorded Jan 22, 2026
From: BAYER CROPSCIENCE LP
To: BAYER CROPSCIENCE LLC
Reel/Frame 074476/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2020
From: CURTIS, DAMIAN
To: BAYER CROPSCIENCE LP
Reel/Frame 053280/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2020
From: THOMPSON, BRIAN
To: SPOGEN BIOTECH INC.
Reel/Frame 053280/0142 →
CHANGE OF ADDRESS Recorded Jul 22, 2020
From: BAYER CROPSCIENCE LP
To: BAYER CROPSCIENCE LP
Reel/Frame 053282/0670 →
Continuity (3)
Continuation 15511839
Provisional Application 62051932 · Sep 17, 2014
Related Publication 20200347102A1 · Nov 5, 2020
Cited By (4)
US 12,351,532 US 12,351,533 US 12,391,729 US 12,630,484